Latest Financial Updates

Read latest financial news update from our blog

Kya HDFCbank Hero se Zero?
Kya HDFCbank Hero se Zero?

Admin | Finance | 2 months ago

Results similar to 'eldorado-gold-ends-2023-with-record-gold-production'
Results similar to 'eldorado-gold-ends-2023-with-record-gold-production'

Admin | Finance | 2 months ago

Russell 2000 Technical Analysis
Russell 2000 Technical Analysis

Yesterday, the Russell 2000 remained under pressure as the market continued to reprice the...

Admin | Finance | 2 months ago

China Has Scrapped Visa Requirements For 11 Nations In Past Year
China Has Scrapped Visa Requirements For 11 Nations In Past Year

Since then, China has expanded its visa-free list — primarily to several European countrie...

Admin | Finance | 2 months ago

U.S. Military Targets Loaded Missiles In Fourth Set Of Strikes Against Houthis
U.S. Military Targets Loaded Missiles In Fourth Set Of Strikes Against Houthis

Topline U.S. forces carried out another set of strikes against Houthi targets in Yemen la...

Admin | Finance | 2 months ago

Synovus Non-GAAP EPS of $0.80 misses by $0.14, revenue of $488.68M misses by $57.4M
Synovus Non-GAAP EPS of $0.80 misses by $0.14, revenue of $488.68M misses by $57.4M

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your...

Admin | Finance | 2 months ago

Richemont reports sales growth of 8% for its third quarter and 11% for its nine months ended 31 December 2023 at constant exchange rates
Richemont reports sales growth of 8% for its third quarter and 11% for its nine months ended 31 December 2023 at constant exchange rates

Official COMPAGNIE FINANCIERE RICHEMONT press release AD HOC ANNOUNCEMENT PURSUANT TO ART...

Admin | Finance | 2 months ago

Argenx Announces Approval of VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis
Argenx Announces Approval of VYVDURA® (efgartigimod alfa and hyaluronidase-qvfc) Injection for Subcutaneous Use in Japan for Generalized Myasthenia Gravis

Official ARGENX SE press release Availability of VYVGART® and self-administered VYVDU...

Admin | Finance | 2 months ago

Join Our Newsletter

join our newsletter to receive update from us